Congenital Pulmonary Airway Malformation (CPAM) - Neonatal Disorders


What is Congenital Pulmonary Airway Malformation (CPAM)?

Congenital Pulmonary Airway Malformation (CPAM), previously known as congenital cystic adenomatoid malformation (CCAM), is a rare developmental anomaly of the lung in which a portion of the lung is replaced by a non-functioning mass of cystic or solid tissue. This malformation can lead to various respiratory issues and complications in newborns and infants.

How Common is CPAM?

CPAM is relatively rare, occurring in approximately 1 in 25,000 to 1 in 35,000 live births. Despite its rarity, it is the most common congenital lung lesion diagnosed antenatally.

What Causes CPAM?

The exact cause of CPAM is unknown. It is believed to result from abnormal lung development during the fetal period, specifically during the pseudoglandular stage of lung development, which occurs between the 5th and 17th weeks of gestation. There is no known genetic component or identifiable risk factor associated with CPAM.

How is CPAM Diagnosed?

CPAM is often diagnosed prenatally through routine ultrasound scans, which can detect abnormal cystic structures in the fetal lungs. If a CPAM is suspected, further imaging such as fetal MRI may be performed to better characterize the lesion. Postnatally, CPAM can be confirmed through chest X-rays, CT scans, or MRI if symptoms arise or if the diagnosis was not made prenatally.

What are the Symptoms of CPAM?

Symptoms of CPAM can vary depending on the size and location of the lesion. Some infants may be asymptomatic and the condition might only be discovered incidentally. Others may present with respiratory distress, recurrent lung infections, or failure to thrive. In severe cases, large lesions can cause compression of normal lung tissue and other thoracic structures, leading to significant respiratory compromise.

How is CPAM Treated?

Treatment of CPAM depends on the size and symptoms of the lesion. Small, asymptomatic lesions might be monitored with regular imaging to ensure they do not grow or cause complications. Symptomatic or large lesions typically require surgical resection, which is often performed in the neonatal period or early infancy. The surgical approach may vary, including lobectomy or segmentectomy, depending on the lesion's location and extent.

What are the Risks and Complications of CPAM?

Potential complications of CPAM include respiratory distress, recurrent lung infections, and the rare possibility of malignant transformation into pleuropulmonary blastoma. Post-surgical complications can include infection, bleeding, and issues related to the removal of lung tissue, such as reduced lung capacity or function.

What is the Prognosis for Children with CPAM?

The prognosis for children with CPAM is generally good, especially if the condition is diagnosed and managed appropriately. Surgical resection of symptomatic lesions usually results in excellent outcomes, with most children leading normal, healthy lives post-surgery. Asymptomatic lesions that are monitored over time tend to have a benign course.

Can CPAM be Prevented?

Currently, there are no known measures to prevent CPAM, as the exact cause remains unknown. Regular prenatal care and ultrasound examinations are crucial for early detection and planning appropriate management strategies.

What is the Role of Pediatricians in Managing CPAM?

Pediatricians play a vital role in the early detection, monitoring, and management of CPAM. They collaborate with pediatric surgeons, radiologists, and other specialists to ensure comprehensive care. Pediatricians also provide support and education to families, helping them understand the condition, treatment options, and the importance of follow-up care.

Partnered Content Networks

Relevant Topics